Home  |  Contact

Cellosaurus AR230-s (CVCL_UC13)

[Text version]
Cell line name AR230-s
Accession CVCL_UC13
Resource Identification Initiative To cite this cell line use: AR230-s (RRID:CVCL_UC13)
Comments Population: Japanese.
Characteristics: Clone of AR230 used as a control cell line for studies using AR230-s which is resistant to imatinib.
Doubling time: ~30-48 hours (ATCC=CRL-3345).
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Sequence variations
  • Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
Disease Chronic myelogenous leukemia, BCR-ABL1 positive (NCIt: C3174)
Chronic myeloid leukemia (ORDO: Orphanet_521)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_9478 (AR230)
Sex of cell Female
Age at sampling 52Y
Category Cancer cell line
STR profile Source(s): ATCC

Markers:
AmelogeninX
CSF1PO10,12
D5S81811,13
D7S82010,11
D13S3178,10
D16S5399,13
TH016
TPOX11
vWA16,20

Run an STR similarity search on this cell line
Publications

PubMed=10910924; DOI=10.1182/blood.V96.3.1070
Mahon F.-X., Deininger M.W.N., Schultheis B., Chabrol J., Reiffers J., Goldman J.M., Vaz de Melo J.
Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance.
Blood 96:1070-1079(2000)

Cross-references
Cell line collections (Providers) ATCC; CRL-3345
Encyclopedic resources Wikidata; Q93325730
Entry history
Entry creation13-Nov-2018
Last entry update29-Jun-2023
Version number7